These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32751716)

  • 1. A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer's Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model.
    Su IJ; Chang HY; Wang HC; Tsai KJ
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer's Disease in APP/PS1 Mice.
    Su IJ; Hsu CY; Shen S; Chao PK; Hsu JT; Hsueh JT; Liang JJ; Hsu YT; Shie FS
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
    Maiti P; Paladugu L; Dunbar GL
    BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
    Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
    Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.
    Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Tonk S; Kuruva CS; Bhatti JS; Kandimalla R; Vijayan M; Kumar S; Wang R; Pradeepkiran JA; Ogunmokun G; Thamarai K; Quesada K; Boles A; Reddy AP
    J Alzheimers Dis; 2018; 61(3):843-866. PubMed ID: 29332042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.
    Gerenu G; Liu K; Chojnacki JE; Saathoff JM; Martínez-Martín P; Perry G; Zhu X; Lee HG; Zhang S
    ACS Chem Neurosci; 2015 Aug; 6(8):1393-1399. PubMed ID: 25893520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 Suppresses Oxidative Stress and Inflammation in
    Uruno A; Matsumaru D; Ryoke R; Saito R; Kadoguchi S; Saigusa D; Saito T; Saido TC; Kawashima R; Yamamoto M
    Mol Cell Biol; 2020 Feb; 40(6):. PubMed ID: 31932477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.
    Bukhari SN; Jantan I
    Mini Rev Med Chem; 2015; 15(13):1110-21. PubMed ID: 26420724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhang HR; Peng JH; Cheng XB; Shi BZ; Zhang MY; Xu RX
    Neurochem Res; 2015 Aug; 40(8):1583-92. PubMed ID: 26068144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 18. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Saito T; Hisahara S; Iwahara N; Emoto MC; Yokokawa K; Suzuki H; Manabe T; Matsumura A; Suzuki S; Matsushita T; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
    Free Radic Biol Med; 2019 Dec; 145():20-32. PubMed ID: 31536772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
    Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
    Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.